Deep Vein Thrombosis News and Research

RSS

Deep vein thrombosis, or DVT, is a blood clot that forms in a vein deep in the body. Most deep vein clots occur in the lower leg or thigh. If the vein swells, the condition is called thrombophlebitis. A deep vein thrombosis can break loose and cause a serious problem in the lung, called a pulmonary embolism, or a heart attack or stroke.

Hypertension, diabetes and obesity are important independent predictors of increased complications for patients undergoing major joint replacement surgery

Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.

1 Jun 2005

Long-haul flights, length of time under anesthesia increase risk of developing blood clots

The prolonged immobility of flight passengers during long-haul air travel increases the risk of developing blood clots, which could prove fatal especially to people whose travel occurs just prior to major surgery, medical researchers report in the current issue of Mayo Clinic Proceedings.

31 May 2005

Endovenous laser ablation is a safe and highly effective treatment for a common cause of varicose veins

Endovenous laser ablation is a safe and highly effective treatment for a common but under-recognized cause of varicose veins -- reflux in a variety of veins collectively referred to as non-great saphenous veins -- according to results of a study presented today at the 30th Annual Scientific Meeting of the Society of Interventional Radiology.

4 Apr 2005

Doctors may in future be able to prevent many cases of deep-vein thrombosis

Doctors may in future be able to prevent many cases of deep-vein thrombosis, commonly referred to as DVT, a disease of the circulation that causes potentially fatal blood clots. It occurs most often in people who have not been able to exercise normally.

9 Mar 2005

Clot-dissolving drugs such as tPA may help detect potentially deadly leg clots

A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.

14 Feb 2005

Ximelagatran effective for preventing blood clots and stroke

A medication that could simplify anticoagulation therapy, ximelagatran, was found to be as effective as other common therapies for preventing stroke and recurrent blood clots

9 Feb 2005

Blood clots in the lungs could be prevented with computed tomography (CT) scans of the legs

Researchers found that indirect CT venography (CTV) could identify blood clots in the legs that have the potential to break free, travel to the lung and block an artery--a life-threatening condition known as pulmonary embolism.

25 Jan 2005

Revlimid clinical data in newly diagnosed multiple myeloma presented

Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.

7 Dec 2004

Surgery for extremely obese patients may be more effective for weight reduction

A new report issued today by HHS’ Agency for Healthcare Research and Quality concludes that surgery for extremely obese patients who have tried and failed to lose weight with exercise and diet may be more effective for weight reduction.

10 Oct 2004

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

New antithrombotic guidelines from the American College of Chest Physicians (ACCP) introduce novel therapies for the prevention and treatment of thrombosis and, for the first time, offer specific recommendations for long-distance travelers.

14 Sep 2004

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Current research supports the use of blood-thinners to help acutely ill, hospitalized patients minimize the risk of death from a pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT).

3 Aug 2004

Surgical flight syndrome: how to reduce the risks

“Most people know that all surgery carries some risk,” says Peter Fodor, President of the American Society for Aesthetic Plastic Surgery (ASAPS). “What is less well known is that airline travel carries risk. So people who combine the two need to take extra precautions,” he says.

15 Jul 2004

Discovery may help those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages

Australian researchers at University of New South Wales have identified a mechanism than can cause blood clots - a discovery with implications for those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages.

7 Jun 2004

BMA calls for action to safeguard the health of air passengers

The British Medical Association is calling for national and international action to safeguard the health of air passengers, in a new report published on Monday (31st May). Despite numbering two billion a year, air travellers are not protected by regulated standards of healthcare or medical advice.

31 May 2004

Anti-clotting treatment underused at many hospitals

Academic hospitals are more likely than community or Veteran’s Administration (VA) hospitals to follow national guidelines for treating patients at risk for blood clots with aspirin or warfarin.

19 May 2004

Computer prescribing systems in UK general practices are endangering patients’ lives

Computer prescribing systems in UK general practices are endangering patients’ lives by failing to pick up on some hazardous drug combinations, say researchers in this week’s British Medical Journal.

14 May 2004

Estrogen-alone hormone therapy had no effect on coronary heart disease risk

A large, multi-center heart disease prevention study, part of the Women's Health Initiative (WHI), found that estrogen-alone hormone therapy had no effect on coronary heart disease risk but increased the risk of stroke for postmenopausal women.

13 Apr 2004

Anti-blood clotting OJ from University of Liverpool

An anti-blood clotting drink has been developed by an up-and-coming biotechnology business based at the University of Liverpool’s Business Incubator, MerseyBIO. Provexis, a medical food company, is in the final stages of its large-scale trial on the new orange juice drink that has been shown to lower the chance of blood clots and thereby reduce risk of heart attack, stroke and the development of deep vein thrombosis.

22 Mar 2004